Bibliometric analysis of traditional Chinese medicine in the treatment of inflammatory bowel disease
Main Article Content
Keywords
bibliometric analysis, CiteSpace, inflammatory bowel disease, traditional Chinese medicine, VOSviewer
Abstract
Objective: This study conducts a bibliometric analysis of literature on the treatment of inflammatory bowel disease (IBD) with traditional Chinese medicine (TCM) to explore its research status, hotspots, and development trends, providing ideas and references for further research.
Method: We screened literature for treating IBD with TCM from the Web of Science Core Collection (WOSCC), and used the VOSviewer software (1.6.18) to discover cooperation among countries, institutions, authors, and information on journals, keywords, etc. We use the CiteSpace software (6.2.R2) to analyze co-citation and burst discovery of references.
Results: In all, 440 relevant literature papers were searched and screened from the WOSCC database. The results showed that the number of publications concerning treating IBD with TCM has shown a significant growth in the past decade. China is far ahead in terms of article output, occupying a dominant position. The institution with the most published articles is Nanjing University of Traditional Chinese Medicine. The authors who have published most of the articles are Dai Yancheng, Shi Rui, and Zhou Lian. The Journal of Ethnopharmacology published maximum articles in this field, while Gastroenterology was the most cited journal. Ungaro et al.’s article entitled “Ulcerative colitis” (https://doi.org/10.1016/S0140-6736(16)32126-2), published in The Lancet in 2017 was the most cited study. The high-frequency keywords mainly include ulcerative colitis, inflammation, NF-κB, expression, traditional Chinese medicine, gut microbiota, activation, mice, cells, etc.
Conclusions: The research heat for treating IBD with TCM has risen over the past decade, with studies focusing on three main aspects: clinical studies of TCM, basic pharmacology, and animal experimental research. The research hotspot shifted from pathogenesis, clinical study of TCM, basic pharmacology, and complementary therapies to the study of network pharmacology and the mechanism of action of TCM related to gut microbiota. Network pharmacology and gut microbiota are at the frontiers of research and turning to be the future research trends to provide new insights and ideas for further research for treating IBD with TCM.
References
2. Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surgical Clin N Am. 2019;99(6):1051–62. 10.1016/j.suc.2019.08.001
3. Baumgart DC, Carding SR. Inflammatory bowel disease: Cause and immunobiology. Lancet (London). 2007;369(9573):1627–40. 10.1016/S0140-6736(07)60750-8
4. de Souza HS, Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13(1):13–27. /10.1038/nrgastro.2015.186
5. Chen M, Ding Y, Tong Z. Efficacy and safety of Sophora flavescens (Kushen)-based traditional Chinese medicine in the treatment of ulcerative colitis: Clinical evidence and potential mechanisms. Front Pharmacol. 2020;11:603476. 10.3389/fphar.2020.603476
6. Pritchard, A. Statistical Bibliography or Bibliometrics?: Journal of Documentation, 1969; 25:348–349.
7. Wang B, Pan S-Y, Ke R-Y, Wang K, Wei Y-M. An overview of climate change vulnerability: A bibliometric analysis based on Web of Science database. Nat Hazards. 2014;74(3):1649–66. 10.1007/s11069-014-1260-y
8. Feng LF, Yan PJ, Chu XJ, Zhang N, Li JY, Li JW, et al. A scientometric study of the top 100 most-cited publications based on Web-of-Science regarding robotic versus laparoscopic surgery. Asian J Surg. 2021;44(2):440–51. 10.1016/j.asjsur.2020.10.026
9. Wang H, Gao T, Zhang R, Hu J, Wang Y, Wei J, et al. The intellectual base and global trends in contrast-induced acute kidney injury: A bibliometric analysis. Renal Fail. 2023;45(1):2188967. 10.1080/0886022X.2023.2188967
10. Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: Visualization and knowledge discovery in bibliographic databases. Annual Symp Proc (AMIA Symp). 2005;2005:724–8.
11. van Eck NJ, Waltman L. Citation-based clustering of publications using CitNet Explorer and VOS viewer. Scientometrics. 2017;111(2):1053–70. 10.1007/s11192-017-2300-7
12. Guo Y, Hao Z, Zhao S, Gong J, Yang F. Artificial intelligence in health care: Bibliometric analysis. J Med Internet Res. 2020;22(7):e18228. 10.2196/18228
13. Shen J, Shen H, Ke L, Chen J, Dang X, Liu B, et al. Knowledge mapping of immunotherapy for hepatocellular carcinoma: A bibliometric study. Front Immunol. 2022;13:815575. 10.3389/fimmu.2022.815575
14. Dayuan Z, Lan L, Luhua X, Huanjie L, Dahao C, Yumiao L, et al. A bibliometric analysis of research-related Chinese medicine in the prevention and treatment of corona virus disease 2019. Heliyon. 2022;8(11):e11120. 10.1016/j.heliyon.2022.e11120
15. Wang J, Chen Y, Zhai X, Chu Y, Liu X, Ma X. Visualizing research trends and identifying hotspots of traditional Chinese medicine (TCM) nursing technology for insomnia: A 18-year bibliometric analysis of web of science core collection. Front Neurol. 2022;13:816031. 10.3389/fneur.2022.816031
16. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet (London). 2017;389(10080):1756–70. 10.1016/S0140-6736(16)32126-2
17. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet (London). 2017;390(10114):2769–78. 10.1016/S0140-6736(17)32448-0
18. Taku K, Britta S, Chen WS, Ferrante M, Shen B, Bernstein CN, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(73):215-4. 10.1038/s41572-020-0205-x
19. Sonnenberg E, Siegmund B. Ulcerative colitis. Digestion. 2016;94(4):181–5. 10.1159/000452621
20. Okobi OE, Udoete IO, Fasehun OO, Okobi T, Evbayekha EO, Ekabua JJ, et al. A review of four practice guidelines of inflammatory bowel disease. Cureus. 2021;13(8):e16859. 10.7759/cureus.16859
21. Xu YH, Zhu WM, Guo Z. Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease. World J Gastroenterol. 2022;28(48):6888–99. 10.3748/wjg.v28.i48.6888
22. Yeganeh PR, Leahy J, Spahis S, Patey N, Desjardins Y, Roy D, et al. Apple peel polyphenols reduce mitochondrial dysfunction in mice with DSS-induced ulcerative colitis. J Nutr Biochem. 2018;57:56–66. 10.1016/j.jnutbio.2018.03.008
23. Xie F, Xiong Q, Li Y, Yao C, Wu R, Wang Q, et al. Traditional Chinese medicine regulates Th17/Treg balance in treating inflammatory bowel disease. Evid Complem Altern Med (Ecam). 2022;2022:6275136. 10.1155/2022/6275136
24. Zhang Y, Yan T, Sun D, Xie C, Wang T, Liu X, et al. Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis. Free Radical Biol Med. 2020;148:33–41 10.1016/j.freeradbiomed.2019.12.012
25. Chen C, Song M. Visualizing a field of research: A methodology of systematic scientometric reviews. PloS One. 2019;14(10):e0223994. ,10.1371/journal.pone.0223994
26. Zhong D, Li Y, Huang Y, Hong X, Li J, Jin R. Molecular mechanisms of exercise on cancer: A bibliometrics study and visualization analysis via CiteSpace. Front Mol Biosci. 2021;8:797902. 10.3389/fmolb.2021.797902
27. Dai YC, Zheng L, Zhang YL, Chen X, Chen DL, Tang ZP. Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial. Medicine. 2017;96(16):e6651. 10.1097/MD.0000000000006651
28. Esters P, Dignass A. Complementary therapies in inflammatory bowel diseases. Current Drug Targets. 2014;15(11):1079–88. 10.2174/1389450115666140903112802
29. Wen Y, Zhang W, Yang R, Jiang L, Zhang X, Wang B, et al. Regulation of Yujin powder alcoholic extracts on ILC3s-TD IgA-colonic mucosal flora axis of DSS-induced ulcerative colitis. Front Microbiol. 2022;13:1039884. 10.3389/fmicb.2022.1039884
30. Wang W, Xu C, Li X, Wang Z, Yang J, Shen Y, et al. Exploration of the potential mechanism of Banxia Xiexin decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis. J Ethnopharmacol. 2021;277:114197. 10.1016/j.jep.2021.114197
31. Xu B-L, Zhang G-J, Ji Y-B. Active components alignment of Gegenqinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stress. J Ethnopharmacol. 2015;162:253–60. 10.1016/j.jep.2014.12.042
32. Tao LJ, Chen WT, Jing L, Ji Q, Ren JL. A network pharmacology approach to establish the pharmacological mechanism of Jia Wei Xian Ji Tang on inflammatory bowel disease. Biomed Rep. 2017;6(3):272–8 10.3892/br.2017.853
33. Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Design Develop Ther. 2021:3255–76. 10.2147/DDDT.S319786
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.